Fluvastatin reduces atherogenic lipids without any effect on native endothelial function early after kidney transplantationASBERG, Anders; HOLDAAS, Hallvard; JARDINE, Alan G et al.Clinical transplantation. 2003, Vol 17, Num 4, pp 385-390, issn 0902-0063, 6 p.Article

Efficacité et efficience des hypolipémiants Une analyse centrée sur les statinesAngéiologie (Paris). 2010, Vol 62, Num 4, pp 24-31, issn 0003-3049, 8 p.Article

A Current Approach to Statin IntoleranceTOMPKINS, R; SCHWARTZBARD, A; GIANOS, E et al.Clinical pharmacology and therapeutics. 2014, Vol 96, Num 1, pp 74-80, issn 0009-9236, 7 p.Article

Statins as Potential Antimalarial Drugs : Low Relative Potency and Lack of Synergy with Conventional Antimalarial DrugsWONG, Rina P. M; DAVIS, Timothy M. E.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 5, pp 2212-2214, issn 0066-4804, 3 p.Article

Suboptimal choices and dosing of statins at start of therapyMANTEL-TEEUWISSE, Aukje K; KLUNGEL, Olaf H; SCHALEKAMP, Tom et al.British journal of clinical pharmacology. 2005, Vol 60, Num 1, pp 83-89, issn 0306-5251, 7 p.Article

Level of awareness of on-treatment patients about prescribed statinsYILMAZ, Mehmet Birhan; BIYIKOGLU, Senay Funda; GURAY, Yesim et al.Cardiovascular drugs and therapy. 2004, Vol 18, Num 5, pp 399-404, issn 0920-3206, 6 p.Article

The pharmaco-economics of peri-operative statin therapyBICCARD, B. M; SEAR, J. W; FOËX, P et al.Anaesthesia. 2005, Vol 60, Num 11, pp 1059-1063, issn 0003-2409, 5 p.Article

The case for statins: has it really been made?THOMPSON, Andrew; TEMPLE, Norman J.Journal of the Royal Society of Medicine. 2004, Vol 97, Num 10, pp 461-464, issn 0141-0768, 4 p.Article

Pleiotropic effects of statins on cardiovascular events in the Japanese Coronary Artery Disease studyFUJITA, Masatoshi; YAMAZAKI, Tsutomu; HAYASHI, Doubun et al.International journal of cardiology. 2008, Vol 129, Num 2, pp 294-296, issn 0167-5273, 3 p.Article

L'activité antifongique des statines = Antifungal activity of statinsLEFEBVRE, M; ALSHAWA, K; DUPONT, B et al.Journal de mycologie médicale. 2010, Vol 20, Num 3, pp 212-217, issn 1156-5233, 6 p.Article

Apport des statines en prévention cardiovasculaire = Benefits of statins in cardiovascular preventionBRUCKERT, Eric; BASTARD, Jean-Philippe.STV. Sang thrombose vaisseaux. 2009, Vol 21, Num 8, pp 347-349, issn 0999-7385, 3 p.Article

In vitro synergistic interactions of the effects of various statins and azoles against some clinically important fungiNYILASI, Iidikó; KOCSUBE, Sándor; KRIZSAN, Krisztina et al.FEMS microbiology letters. 2010, Vol 307, Num 2, pp 175-184, issn 0378-1097, 10 p.Article

Persistence and determinants of statin therapy among middle-aged patients for primary and secondary preventionPERREAULT, S; BLAIS, L; LAMARRE, D et al.British journal of clinical pharmacology. 2005, Vol 59, Num 5, pp 564-573, issn 0306-5251, 10 p.Article

Statins as Antithrombotic DrugsVIOLI, Francesco; CALVIERI, Camilla; FERRO, Domenico et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 2, pp 251-257, issn 0009-7322, 7 p.Article

Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword?BALAKUMAR, Pitchai; MAHADEVAN, Nanjaian.British journal of pharmacology. 2012, Vol 165, Num 2, pp 373-379, issn 0007-1188, 7 p.Article

Serum total cholesterol, statins and cognition in non-demented elderlySOLOMON, A; KAREHOLT, I; NGANDU, T et al.Neurobiology of aging. 2009, Vol 30, Num 6, pp 1006-1009, issn 0197-4580, 4 p.Article

Beneficial cardiovascular pleiotropic effects of statinsDAVIGNON, Jean.Circulation (New York, N.Y.). 2004, Vol 109, Num 23, pp III.39-III.43, issn 0009-7322, SUPArticle

Statin effects beyond lipid lowering: are they clinically relevant?BONETTI, P. O; LERMAN, L. O; NAPOLI, C et al.European heart journal. 2003, Vol 24, Num 3, pp 225-248, issn 0195-668X, 24 p.Article

The inhibitory effect of statins on urinary 11-dehydrothromboxane levelsALUSIK, S; PALUCH, Z; LEJSKOVA, M et al.International angiology. 2010, Vol 29, Num 3, pp 255-259, issn 0392-9590, 5 p.Article

Being well-informed about statin is associated with continuous adherence and reaching targetsYILMAZ, Mehmet Birhan; PINAR, Murat; NAHARCI, Ilkin et al.Cardiovascular drugs and therapy. 2006, Vol 19, Num 6, pp 437-440, issn 0920-3206, 4 p.Article

Association of dyslipidemia and effects of statins on nonmacrovascular diseasesBAGHDASARIAN, Sarkis B; JNEID, Hani; HOOGWERF, Byron J et al.Clinical therapeutics. 2004, Vol 26, Num 3, pp 337-351, issn 0149-2918, 15 p.Article

Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001TONSTAD, S; ROSVOLD, E. O; FURU, K et al.Journal of internal medicine. 2004, Vol 255, Num 4, pp 494-502, issn 0954-6820, 9 p.Article

IV thrombolysis and statinsENGELTER, S. T; SOINNE, L; ZINI, A et al.Neurology. 2011, Vol 77, Num 9, pp 888-895, issn 0028-3878, 8 p.Article

Statins in dermatologyJOWKAR, Farideh; MOHAMMAD REZA NAMAZI.International journal of dermatology. 2010, Vol 49, Num 11, pp 1235-1243, issn 0011-9059, 9 p.Article

The Acute (Cerebro)Vascular Effects of StatinsPRINZ, Vincent; ENDRES, Matthias.Anesthesia and analgesia. 2009, Vol 109, Num 2, pp 572-584, issn 0003-2999, 13 p.Article